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Abstract
Background: Adenovirus protein, Gam1, triggers the proteolytic destruction of the E1 SUMO-activating enzyme.
Microinjection of an empirically determined amount of Gam1 mRNA into one-cell Xenopus embryos can reduce
SUMOylation activity to undetectable, but nonlethal, levels, enabling an examination of the role of this post-
translational modification during early vertebrate development.
Results: We find that SUMOylation-deficient embryos consistently exhibit defects in neural tube and heart
development. We have measured differences in gene expression between control and embryos injected with Gam1
mRNA at three developmental stages: early gastrula (immediately following the initiation of zygotic transcription),
late gastrula (completion of the formation of the three primary germ layers), and early neurula (appearance of the
neural plate). Although changes in gene expression are widespread and can be linked to many biological
processes, three pathways, non-canonical Wnt/PCP, snail/twist, and Ets-1, are especially sensitive to the loss of
SUMOylation activity and can largely account for the predominant phenotypes of Gam1 embryos. SUMOylation
appears to generate different pools of a given transcription factor having different specificities with this post-
translational modification involved in the regulation of more complex, as opposed to housekeeping, processes.
Conclusions: We have identified changes in gene expression that underlie the neural tube and heart phenotypes
resulting from depressed SUMOylation activity. Notably, these developmental defects correspond to the two most
frequently occurring congenital birth defects in humans, strongly suggesting that perturbation of SUMOylation,
either globally or of a specific protein, may frequently be the origin of these pathologies.
Keywords: SUMO, Heart development, Neural tube development, Congenital birth defects, Non-canonical Wnt
signaling, Planar cell polarity
Background
Post-translational modification by small ubiquitin-like modi-
fier (SUMO) has emerged as a global mechanism for the
regulation of protein activity, stability, and localization [1–5].
Its integration into other types of protein modification, such
as phosphorylation, acetylation, and ubiquination, allows for
coordinated control of diverse biological processes. Although
the SUMO (E2) conjugating enzyme is capable of acting dir-
ectly on target proteins, in the majority of cases a sizable
family of SUMO (E3) ligases determine substrate specificity.
The SENP family of proteases, likewise exhibiting different
specificities, acts to remove SUMO moieties so that the
modification is reversible and can be tightly regulated.
The steady-state level of SUMOylated protein in any
given instance is typically low and has been referred to
as the “SUMO enigma” [6]. This has made detection of
SUMO-modified proteins difficult. Nonetheless, a strat-
egy that employed the expression of epitope-tagged
SUMO2 in human cells combined with flow cytometry
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enabled the identification of more than 1600 proteins
conjugated to this SUMO isoform [4]. Similar to earlier
studies with yeast cells [5, 7], SUMO modification in this
case was mostly limited to nuclear proteins or those that
are nucleocytoplasmic. This is consistent with the large
number of transcription factors, RNA binding proteins,
chromatin associated proteins, and cell cycle regulators
that are documented targets of SUMOylation [8, 9]. In
Xenopus egg extract, a large number of SUMOylated
proteins are associated with chromatin [10]. However, a
bioinformatic analysis of this proteomic data revealed
that an appreciable number (39.5%) of the identified
SUMOylated proteins were linked to metabolic pro-
cesses and translation, indicating the importance of this
post-translational modification in cytoplasmic processes
as well.
The importance and scope of SUMOylation during
early development has been difficult to ascertain, since
complete elimination of this activity is embryonic lethal
[2, 8, 11–13]. From yeast to vertebrates, the essential
role of SUMOylation in mitotic processes has defeated
approaches that have knocked out this pathway by elim-
ination of the sole E2 conjugating enzyme. Strategies
that have eliminated only one of the SUMO isoforms
have resulted in less severe phenotypes in the case
of SUMO1 [14–16], but embryonic lethal phenotypes
in the case of SUMO2 [17]. Gene knockout or other
methods of gene inactivation that target other com-
ponents of the SUMOylation machinery (i.e., E3 li-
gases and SENP proteases) result in a variety of
phenotypes [11].
A means to diminish, but not eliminate, SUMOylation
activity would enable an assessment of the pathway’s im-
portance and ubiquity during early development. The
avian adenovirus protein, Gam1, binds to the SAE1 sub-
unit of the E1 SUMO-activating enzyme and triggers its
proteolytic degradation [18, 19], and injection of mRNA
encoding Gam1 into Xenopus embryos reduces SUMOy-
lation activity to undetectable levels [20]. Here, we have
used Gam1 in order to measure changes in gene expres-
sion in SUMOylation-deficient embryos at three devel-
opmental stages, early gastrula, late gastrula, and early
neurula using microarray technology, which can analyze
the activity of approximately 30,000 genes. The data
show that SUMOylation impacts many disparate bio-
logical processes; nonetheless, certain signaling pathways
appear to be particularly sensitive to depletion of this ac-
tivity and can be correlated with the predominant phe-
notypes of these embryos that include failure of
blastopore and neural tube closure, shortened
anterior-posterior (A-P) axis, and defective heart and eye
development. Importantly, we show that disruptions in
these pathways due to loss of this post-translational
modification during the earliest periods of
embryogenesis can elicit developmental deficits that cor-
respond to the most frequently occurring human birth
defects.
Results and discussion
Gam1 depletion of SUMOylation activity in Xenopus
embryos
The adenovirus protein Gam1 triggers the proteolytic
destruction of the SUMO E1 activating enzyme [18, 19],
providing a strategic alternative to antisense methods,
since the effect is immediate and eliminates both exist-
ing and de novo accumulation of the activating enzyme.
We have reported that injection of mRNA encoding
Gam1 into one-cell Xenopus embryos suppresses
SUMOylation activity to undetectable levels in extract
prepared from early neurula stage embryos [20]. In order
to characterize the activity of Gam1 further, we mea-
sured the persistence of the protein during development.
Fertilized eggs were injected with mRNA (0.5 ng) encod-
ing myc-tagged Gam1; protein extract prepared from
embryos at the designated developmental stage was ana-
lyzed by western blot. Gam1 protein is present by mid-
blastula stage and reaches a maximum during early
gastrula before declining during neurulation (Fig. 1a).
An in vitro assay containing E1, E2 (UBC9), SUMO1,
and a 25 kDa substrate peptide was used to measure
SUMOylation activity by western blot (Fig. 1b). The ef-
fect of different amounts of injected Gam1 mRNA on
SUMOylation activity was determined at four stages of
development using whole cell extract prepared from
water or Gam1 injected embryos as a source of E1 en-
zyme in the in vitro assay (Fig. 1c). All three amounts of
injected Gam1 mRNA effectively suppress SUMOylation
activity at midblastula. However, at late blastula there is
measureable SUMOylation activity in all samples, pre-
sumably due to the approximate 2-fold increase during
mid- and late blastula in the mRNAs that encode the
two subunits (SAE and UBA2) that comprise the E1 en-
zyme [21]. Suppression of SUMOylation activity is rees-
tablished in early gastrula embryos (0.5 or 1 ng injected
mRNA) that then persist until late neurula. The excel-
lent correlation between the levels of Gam1 protein and
suppression of E1 activity is in accord with other evi-
dence that expression of the viral protein is an effective
method to control the SUMO pathway [18, 19]. The
transient appearance of SUMOylation activity at the
midblastula transition (MBT) possibly accounts for the
survival of these embryos. Injection of higher amounts
(5 ng) of Gam1 mRNA is lethal with no survival of
injected embryos beyond the gastrula-neurula transition
(stage 13). A mutant form of Gam1 that cannot bind to
the SAE1 subunit had no effect on viability when
injected at the same amount. Based on these results, 0.5
ng of injected Gam1 mRNA was chosen for the
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subsequent experiments to examine the role of SUMOy-
lation in developing embryos.
Distinct phenotypes in SUMOylation deficient Xenopus
embryos
Embryos injected with Gam1 mRNA develop normally
up through late blastula compared to water injected or
uninjected control embryos. One of the earliest pheno-
types of Gam1 embryos is delayed or incomplete closure
of the blastopore, which is a hallmark of gastrulation
(Fig. 2a). In instances where closure is simply slowed,
the embryo usually develops normally after this point.
Embryos, in which the blastopore fails to close, do not
develop normally and exhibit cascading effects that are
apparent at the neurula stage of development. During
neurulation, the neural tube forms due to convergent ex-
tension of the outermost layer of cells on the embryo
[22, 23]. The posterior portion of the neural tube closes
at or very near to the point of blastopore closure. There-
fore, when the blastopore fails to close properly, the
neural tube also fails to close properly and embryos dis-
play a spina bifida like phenotype at the late neurula
stage. In the most extreme cases, embryos injected with
Gam1 present completely open neural tubes with failure
of the neural folds to fuse together along the entire A–P
axis (Fig. 2b).
Embryos that are viable at the late neurula stage usu-
ally develop into free-swimming tadpoles (> 48 hpf).
Gam1 injected embryos at this stage of development
have shortened or bent axes often due to the failure of
the neural tube to close properly. Additionally, the ma-
jority of embryos display some degree of edema, or fluid
collection, in the ventral regions of the embryo specific-
ally around the heart and digestive system (Fig. 2b).
Along with edema and a shortened axis, embryos display
defects in eye, heart, and gut development, including
cyclopia or eyes that are not fully separate (fused eye)
(Fig. 2c) and disordered digestive system.
Defects in the heart include improper looping, disrup-
tion of chamber formation, and an absence of blood
flow. Normal amphibian hearts contain three chambers,
two atria and one ventricle, with looping of the outflow
track to the right. Hearts of Gam1-injected embryos
often lack discernible chambers and seem to have not
developed beyond a heart tube structure due to a failure
of proper looping (Fig. 2d). Heart structures that have
Fig. 1 Depletion of SUMOylation activity in embryos injected with Gam1 mRNA. a Expression levels of Gam1 protein during embryogenesis. One-
cell embryos were injected with mRNA (0.5 ng) encoding Gam1 with an N-terminal myc tag. Whole cell protein extract was prepared from
embryos at the indicated Nieuwkoop–Faber stage and 25 μg taken for western blot analysis using anti-myc antibody. Lanes: 1, midblastula; 2, late
blastula; 3, early gastrula; 4, early neurula; 5, late neurula; 6, water injected control. b In vitro SUMOylation assay. All assays contained Ubc9 (E2
enzyme), SUMO1, ATP, and substrate peptide (25 kDa) with (lane 1) or without (lane 2) purified E1 enzyme (500 nM) added. Samples were
analyzed by western blot using an antibody specific for a 25 kDa SUMO substrate peptide. c Assays for E1 activity. One-cell embryos were
injected with the indicated amount of Gam1 mRNA and allowed to develop to the indicated stage. Whole cell extract was prepared from 20
embryos and an equivalent amount of protein (25 μg) was used as a source of E1 enzyme for each assay
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formed contain little to no blood past the stage in devel-
opment when control matched embryos have begun pro-
ducing blood. Surprisingly, these embryos are viable and
have heart structures that continue to beat, although
contractions are erratic. Defects in the formation of
these organs indicate that the temporary disruption of
SUMOylation activity during early embryogenesis im-
pacts the developmental program long after this activity
is restored.
Inhibition of SUMOylation activity disrupts convergence
and extension
The phenotypes of a shortened A–P axis and failure of
the blastopore and neural tube to close in the Gam1 em-
bryos indicate that SUMOylation activity is necessary for
convergence and extension. Information concerning the
involvement of SUMO in cell movement is limited. A
morpholino oligonucleotide directed at SUMO1 pre-
vented activin-induced elongation of Xenopus animal
caps [15] and SUMOylation of Rac1 GTPase is needed
for optimal cell migration in response to hepatocyte
growth factor [24]. Since cell movement during gastrula-
tion is primarily internal and cannot be easily observed,
we turned to Keller explant assays to determine whether
the SUMOylation deficiency in Gam1 embryos impacts
this activity [25]. Explants are made by sandwiching to-
gether a portion of two embryos dorsal to the blastopore
lip, which contain migrating cells. This arrangement
causes the mesodermal and endodermal cells to elongate
in a plane rather than involuting beneath ectodermal
cells, enabling quantification of the degree of convergent
extension.
Control embryos (injected with H2O) showed normal
convergent extension while those injected with 2.5 ng
Gam1 mRNA failed to elongate properly (Fig. 3a). Add-
itionally, when the amount of Gam1 mRNA was doubled
to 5.0 ng, explants not only showed no evidence of cell
movement, but the two explants failed to adhere to each
other. This indicates not only a role of SUMOylation in
controlling cell migration, but also in controlling cell
adhesion.
The degree of explant convergent extension was quan-
tified by measuring the boundary of the non-involuting
and involuting marginal zones (convergence) and the an-
terior to posterior length (extension) (Fig. 3b, c).
Two-tailed t-tests show that both convergence (p <
0.001) and extension (p < 0.00005) are significantly de-
creased in Gam1 embryos compared to controls. The
disruption of these activities explains, at least in part,
many of the observed phenotypes of Gam1 embryos.
Gene expression in SUMOylation deficient Xenopus
embryos
Gam1 knockdown of SUMOylation activity reproducibly
generated distinct developmental phenotypes, several of
which have been previously linked to disruptions of this
Fig. 2 Developmental defects of Gam1-injected embryos. a Control (left) and Gam1-injected (right) late gastrula stage embryos showing delayed
closure of the blastopore (arrow) in the latter. b Stage 35 (50 hpf) control embryo (left), Gam1 embryo with shortened A–P axis (center), Gam1
embryo with an open neural tube and edema around the heart (right). c An example of an eye defect (cyclopia). d Failure of the heart tube to
initiate looping. (Left) A control embryo (96 hpf) in which the two atria (red) and ventricle (black) have fully developed compared to (right) a
Gam1 embryo in which the heart tube has failed to undergo looping
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post-translational modification, including neural tube
closure [26], cleft lip/palate [27], heart defects [28–30],
axial mesodermal defects that lead to midline pheno-
types such as cyclopia [31], and disruption of
hematopoiesis [32]. In good accord with the Gam1 phe-
notypes, a morpholino antisense oligonucleotide directed
against Xenopus SUMO1 caused shortened and bent
A-P axes, incomplete closure of the neural tube, micro-
cephaly, and inhibition of activin-induced elongation of
animal caps [15]. The close correspondence between the
morphlino and Gam1 phenotypes affirm that the effects
resulting from Gam1 expression are chiefly due to inter-
ference of SUMOylation activity in these embryos.
The ability to decrease SUMOylation activity to nonle-
thal levels presents the opportunity to examine the role
of this protein modification, which frequently targets
transcription factors and several other nuclear proteins,
in the regulation of gene expression during early
Fig. 3 Gam1 disrupts convergence and extension. a Examples of Keller sandwich explants prepared from embryos injected with (i) water, (ii) 2.5
ng Gam1 mRNA, (iii) 5 ng Gam1 mRNA. Explants from embryos injected with water (n = 17) or 2.5 ng Gam1 mRNA (n = 18) were measured to
quantify effects on b convergence and c extension. The red lines designate the lengths measured in the explants. Center lines in plots show the
medians; box limits indicate the 25th and 75th percentiles; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles
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development. Three developmental stages were chosen
for transcriptome analysis (30,000 genes) by microarray:
early gastrula (stage 10), which shortly follows the initi-
ation of zygotic transcription at the MBT; late gastrula
(stage 12), which is at the end of a period of complex
cell movement that organizes the three germ layers; and
early neurula (stage 14), which marks changes in tran-
scription that underlie organogenesis and patterning of
the embryo. Three biological replicates were analyzed in
order to account for variation between egg clutches. The
R-values of scatter plots of the biological replicates
ranged from 0.959 to 0.916, demonstrating excellent cor-
relation between each of the replicates. The number of
differentially expressed genes (p < 0.05) between control
(water injected) and Gam1 embryos numbers 94 (53
down-regulated, 41 up-regulated) at early gastrula; 447
(263 down-regulated, 221 up-regulated) at late gastrula;
and 742 (394 down-regulated, 387 up-regulated) at early
neurula. A heatmap of all differentially expressed genes
identified from comparisons between control and Gam1
injected embryos at the three developmental stages is
presented in Additional file 1: Figure S1. An accompany-
ing data matrix contains the gene names and expression
values in the order in which they appear in the heatmap
(Additional file 2: Table S1).
In order to validate the microarray data, the same
RNA samples were used for qRT-PCR assays of genes
selected based upon either the magnitude of the change
in expression (dmrta1, rpl8, ccng1), the occurrence of
the gene in a pathway involved in patterning the early
embryo (xbra, foxc1, wnt8b, gsc, chrd), or a previous
microarray analysis of X. laevis development (xpo1,
wnt8b, krt) [33]. (A graphical comparison of the micro-
array and qRT-PCR data is presented in Additional file 3:
Figure S2). The expected correlation between microarray
and qRT-PCR is 80–87% with respect to the direction of
the change (up- versus down-regulation) [33, 34]. The
correlation between our microarray and qRT-PCR assays
is 93%; these results, along with the scatter plots, indi-
cate that the quality of the microarray data is high.
There is also good agreement between the two measure-
ments with regard to quantitation, especially for those
genes that show the greatest up- (ccng1 and xpo) and
down-regulation (dmrta1).
Biological process ontology of differentially expressed
genes
Differentially regulated genes for each time point were as-
sembled into gene lists for analysis using data mining soft-
ware including MetaCore, BiNGO, DAVID, and the Gene
Ontology database [35]. Xenopus gene lists were converted
to their human equivalents for analyses using these appli-
cations. Volcano plots (Additional file 4: Figure S3) display
statistical significance (p value) versus fold change at each
time point. These plots reflect not only the increasing
number of differentially expressed genes progressing from
early gastrula to early neurula, but also the increasing
magnitude of these differences. With few exceptions, most
changes in expression at early gastrula are only 20–30%;
whereas, larger quantitative changes are seen at the later
two time points. We have used these lists of genes affected
by the loss of SUMOylation activity for various bioinfor-
matics analyses in order to understand the regulatory role
of this post-translational modification during early verte-
brate development.
The first analysis was to determine the predominant
(high level) biological processes affected by loss of
SUMOylation activity at the three different developmen-
tal time points (Fig. 4). The profiles at these three stages,
which span a total of about 7 h, are distinctly different.
However, the distribution of affected genes among these
biological processes seems to reflect the major cellular
activities of embryos at each of these stages. With
lengthening of the cell cycle, zygotic transcription begins
at the MBT and transcriptome analysis at early gastrula
is expected to capture this transition. Indeed, many of
the differentially expressed genes at this time point nor-
mally show robust induction between Nieuwkoop–Faber
stages 8 and 10 [36]. The greatest proportion of affected
genes at early gastrula are concerned with Regulation
(31%) and Metabolism (18%), primarily as a result of the
resumption of transcription and protein synthesis.
The expression of 9 out of 94 differentially expressed
genes are assigned to Developmental Processes in the
early gastrula embryos, of which the most notable are
foxc1, foxd1 and twist. All three of these genes, which
are highly expressed in mesoderm, can be correlated
with morphological phenotypes that later appear in the
Gam1 embryos (e.g., deficits in heart and neural tube de-
velopment). Although GeneGo did not place sox2, a key
regulator of neural induction, under Developmental Pro-
cesses, it is nonetheless notable that its expression is re-
duced 1.7-fold at early gastrula and remains modestly
lower (1.4-fold) at late gastrula.
The most striking change between early and late gas-
trula embryos is the greatly increased percentage of
genes that fall under Developmental Processes (increas-
ing from 9 to 34%) and Multicellular Organism Pro-
cesses (increasing from 10 to 23%). Indeed, only four
high level biological processes predominate at late gas-
trula. At this time point, several additional members of
the Fox family of transcription factors appear in the list
of differentially expressed genes ascribed to Develop-
mental Processes as well as genes encoding proteins in-
volved in Wnt, ephrin, and TGF-β signaling, which are
all known to play critical roles during gastrulation.
Although the percentage of genes ascribed to Develop-
ment Processes decreases in early neurula embryos to
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16% of the total of differentially expressed genes, the ac-
tual number increases, showing that SUMOylation con-
tinues to play an important regulatory role in
development. While the genes for many of the afore-
mentioned transcription factors and signaling molecules
remain mis-regulated, now multiple Hox genes are re-
pressed in the Gam1 embryos at this time point, which
is consistent with their normally strong induction during
late gastrula stage. Whereas, SUMOylation is often asso-
ciated with transcriptional repression, several of the Hox
genes seemingly require this post-translational modifica-
tion for activation.
Of special note, expression of the homeobox protein,
Pitx2, is down 4-fold at early neurula in Gam1 embryos.
This transcription factor is critical for eye development,
as well as the formation of asymmetric organs such as
the heart and gut, whose perturbation is a predominant
phenotype of the SUMOylation deficient embryos. Pitx2
along with foxc1 (down 2.7-fold at early gastrula) are
both implicated in Axenfeld-Rieger syndrome. The lists
of genes that are categorized into the various biological
processes can be found in Additional file 5: Table S2.
Transcription factor network building
The regulation of transcription by SUMOylation can
occur on multiple levels that include, for example,
changes in chromatin structure (e.g., histone modifica-
tion and nucleosome positioning) and subnuclear
localization (e.g., PML bodies). However, the most com-
mon mechanism is likely through the SUMOylation of
transcription factors. We used the network building al-
gorithm ‘Transcription Factor Regulation’ to identify
common transcription factors that control the maximum
number of differentially expressed genes in Gam1 em-
bryos. This algorithm adds a transcription factor to a
gene list as a seed node, and builds a network of interac-
tions around it. Gene lists from each time point were an-
alyzed separately and the top 30 transcription factors at
each time point were returned (Table 1). The connec-
tions made within each network are based on direct con-
trol of the target gene by the seed transcription factor
and, inversely, target gene control of the seed transcrip-
tion factor. The lists of transcription factors at each time
point are quite similar and include those such as Sp1,
HNF4-α, c-myc, and p53, that regulate an especially
large number of different genes.
In order to determine if these transcription factors are
highly associated with genes controlled by SUMOylation,
the same analysis was carried out using the lists of genes
not affected by Gam1, which number 11,702 genes from
early gastrula, 11,322 genes from late gastrula, and
11,019 genes from early neurula (Table 1). The list of
transcription factors connected to changed versus un-
changed genes is strikingly similar. At early gastrula, 18
out of 30 transcription factors were common to both
sets of genes with the top 5 factors being identical. For
the late gastrula, 21 out of 30 factors are common and
again the top 5 are identical. At the early neurula, 20 out
of 30 factors are common with the top 5 factors
remaining identical between the lists. Of the top 5 tran-
scription factors, four are common across all three time
points (SP1, HNF4-α, c-myc, p53). The simplest inter-
pretation of this analysis is that these transcription fac-
tors emerge solely because they bind to an unusually
large number of regulatory sites throughout the genome,
a subset of which are regulated by SUMOylation.
Interestingly, the GO biological processes associated
with any specific transcription factor are different de-
pending on whether the gene list is built from those
changed by Gam1 or those unaffected by Gam1 (Add-
itional file 6: Table S3). For example, the two top tran-
scription factors at early gastrula are Sp1 and HNF4-α.
The GO processes most highly associated with Sp1 in
Gam1 embryos are eye, sensory organ, and embryo de-
velopment; whereas, in control embryos they are meta-
bolic processes. It is especially noteworthy that
Fig. 4 Biological processes most affected by loss of SUMOylation activity. Functional enrichment analysis of differentially expressed genes at each
time point based on GeneGo categorization of annotated protein function. Only selected groups containing the largest number of genes
are presented
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SUMOylation of Sp1 has been directly implicated in
Xenopus eye development [37]. For HNF4-α, the
enriched GO processes in Gam1 embryos are dendrite
morphogenesis, signaling pathways, microtubule
polymerization, and cell communication; the GO pro-
cesses in control embryos are almost entirely metabolic.
This analysis indicates that constitutive genes necessary
for organism viability, e.g., metabolism and biosynthesis,
are mostly controlled in a SUMO-independent manner.
Conversely, genes with complex expression patterns are
more likely controlled by transcription factors whose ac-
tivity is modulated by SUMOylation. This GO analysis
also suggests that SUMO modification generates distinct
pools of a particular transcription factor in order to
regulate specific subsets of genes, with SUMOylated
forms of these transcription factors biased towards more
highly regulated (e.g., cell type, temporal) processes. This
view is supported by studies in Drosophila where muta-
tions in the SUMO E1 activating enzyme had no effect
on larval growth, but did cause defects in imaginal disk
formation [38].
A total of 50 different transcription factors were iden-
tified through the Transcription Factor Regulation algo-
rithm as being associated with genes differentially
expressed at one or more time points. These factors
were analyzed for potential SUMOylation sites and SIMs
Table 1 Transcription Factor Network Buildinga
Differential Gene Expression Constant Gene Expression
Early Gastrula (94) Late Gastrula (447) Early Neurula (742) Early Gastrula (11,702) Late Gastrula (11,322) Early Neurula (11,019)
SP1 15 HNF4α 104 SP1 119 HNF4α 1372 HNF4α 1335 HNF4α 1313
HNF4α 14 SP1 101 HNF4α 114 SP1 1082 SP1 1053 SP1 1028
c-Myc 13 c-Myc 92 c-Myc 106 c-Myc 1033 c-Myc 1002 c-Myc 987
p53 9 ESR1 75 p53 77 p53 486 p53 461 p53 460
Oct-3/4 7 p53 67 ESR1 69 ESR1 479 ESR1 463 ESR1 455
STAT3 6 E2F1 60 C/EBPβ 50 CREB1 467 CREB1 452 CREB1 451
CREB1 6 NF-Y 59 NF-kB 45 AP-1 378 AP-1 370 AP-1 365
YY1 5 AR 58 STAT1 38 NF-Y 310 E2F1 335 E2F1 332
HNF1α 4 EGR1 54 AR 37 E2F1 342 NF-Y 301 NF-Y 303
Sry 4 c-Jun 53 CREB1 37 NF-kB 314 NF-kB 302 NF-kB 298
FKHR 4 ETS1 53 HSF1 36 AP-2 306 AP-2 300 YY1 294
SRF 4 GCRα 53 MYOD 36 YY1 303 EGR1 293 AP-2 293
NANOG 4 YY1 52 SRF 36 EGR1 300 YY1 290 EGR1 289
E2F1 4 Oct-3/4 51 EGR1 36 GATA-1 283 GATA-1 276 GATA-1 266
ETS1 4 RelA 51 E2F1 36 Elk-1 214 Elk-1 211 Elk-1 206
EGR1 4 Oct-1 50 AP-1 35 ETS1 250 ETS1 248 ETS1 242
HIF1A 4 SRF 50 RelA 34 AR 258 AR 255 AR 249
AP-2 3 HIF1A 50 C/EBPα 32 HIF1A 236 HIF1A 233 Oct-3/4 232
ATF-6 α 3 MYOD 49 p21 32 C/EBPβ 235 C/EBPβ 230 c-Jun 224
RelA 3 C/EBPβ 49 ATF-2 31 Oct-3/4 236 E2F4 228 E2F4 223
C/EBPα 3 Bcl-6 48 YY1 29 c-Jun 233 Oct-3/4 227 HIF1A 222
ER81 3 TCF7L2 48 HIF1A 29 E2F4 229 c-Jun 222 C/EBPβ 217
HSF1 3 HSF1 48 p63 29 RelA 224 RelA 216 RelA 214
ESR1 3 HNF6 48 SP3 28 SP3 206 SP3 203 SP3 199
USF2 3 E2F4 47 NF-Y 28 GCRα 205 SRF 188 GCRα 198
AP-1 3 SMAD3 47 AP-4 28 HNF6 205 AP-2A 197 HNF6 198
AR 3 SOX4 47 c-Jun 27 Oct-1 202 HNF6 197 AP-2A 194
MYOD 3 STAT1 46 GATA-1 26 AP-2A 200 Oct-1 195 Oct-1 192
FOXO3A 3 c-Myb 46 STAT3 26 AHR 192 GCRα 195 HNF1α 187
AP-2A 3 SREBP1 46 Oct-3/4 24 HNF1α 192 AHR 189 SRF 185
aTop 30 transcription factors associated the largest number of genes that are either differentially expressed or constant across developmental stages of Gam1
embryos built using the Transcription Factor Regulation algorithm in MetaCore. Numbers indicate the number of genes used for network building in each case
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using the SUMO prediction site algorithm GPS–SUMO
[39]. Of the 50 transcription factors, 46 (92%) contain
consensus SUMOylation sites, only 1 has no identifiable
site, and 3 lack sufficient sequence information to make
a prediction (Additional file 7: Table S4). To date, 29 of
the 46 have been experimentally verified to be SUMOy-
lated. SIMs appear in 42 of the listed transcription fac-
tors. The fact that nearly all of factors identified by
network building are targets of SUMOylation and/or
contain SIMs indicates that the majority of changes in
gene expression induced by Gam1 are due directly to
changes in factor activity as a result of this
post-translational modification.
The Transcription Factor Regulation algorithm returns
the most highly connected factors for a given gene list.
A shortcoming of this analysis is that critical transcrip-
tion factors may be overlooked, if they regulate a small
fraction of genes in the entire list. As an example, the
gene list at early gastrula was examined manually using
a variety of sources to identify candidate transcription
factors for each gene. As expected, we found that the
transcription factors listed in Table 1 are associated with
many of the differentially expressed genes in the list.
However, we also found that the transcription factor
Nkx2.5, whose role in cardiac differentiation is regulated
by SUMOylation [28], has predicted binding sites at the
promoters of a subset of these differentially expressed
genes (alkbh6, evx1, fam184a, foxc1, foxd1, fzd10a,
gapvd1, twist1/2). Of these putative targets of Nkx2.5,
foxc1 is particularly significant, since foxc1-depleted Xen-
opus embryos exhibit similar phenotypes to the
Gam1-injected embryos: shortened A–P axis and abnor-
mal heart and gut development [40]. Moreover, a mor-
pholino knockdown of foxc1 protein caused changes in
the expression levels of casein kinase 1 epsilon, insulin--
like growth factor 2, and keratin 8 mRNAs [40] that we
also detect in the early neurula embryos.
The heart defects of Gam1-injected embryos are certainly
not due to foxc1 alone. We also measured reductions of
other key cardiac regulatory factors such asmespa (1.6-fold),
tbx2 (2.1-fold), and tbx3 (2.3-fold) at late gastrula and pitx2
(4.0-fold) at early neurula. Thus, the potential effects of de-
pleted SUMOylation activity on heart development are
seemingly propagated through the three stages sampled in
this study. Twist, which is down regulated at early gastrula
and considerably more at late gastrula, has also been impli-
cated in cardiogenesis (reviewed in [41]). Thus, the predom-
inant phenotypes in heart development can be explained by
multiple effects on the cardiac transcription program that
results from depletion of SUMOylation activity.
Co-expression analysis
The expression of the differentially expressed genes were
compiled across the three time points and compared
using the module/cluster detection algorithm imple-
mented in R package WGCNA [42]. The differentially
regulated genes were compiled into eight syn-expression
clusters based on the similarity of expression changes
across all three time points. The gene lists from individ-
ual clusters were analyzed using the MetaCore transcrip-
tional regulation algorithm. Each cluster returned a
similar set of top transcription factors that are similar to
the individual lists returned for both the differentially
expressed and unchanged genes (Table 1). This observa-
tion further supports the idea that the most highly con-
nected transcription factors are those that are widely
used to control the greatest number of genes in any list.
This strongly argues that co-expression in this case can-
not be traced to a single transcription factor or set of
transcription factors acting as master regulators.
Signaling pathways sensitive to diminished SUMOylation
activity
We chose a non-lethal level of Gam1 expression in order
to identify developmental processes that are potentially
regulated by SUMOylation. This strategy will only iden-
tify those that are most sensitive to loss of this activity.
Because the effects of this post-translational modifica-
tion are widespread and not limited to gene regulatory
proteins, we have used the predominant phenotypes of
Gam1-injected embryos as a guide to examine some of
the signaling pathways that appear to be the most vul-
nerable to this perturbation. The list of differentially
expressed genes was uploaded into MetaCore and ana-
lyzed for their presence in known biochemical pathways.
Analysis focused on those pathways with outcomes re-
lated to the observed phenotypes of failed blastopore or
neural tube closure, shortened A–P axis, and cardiovas-
cular deformations. Three pathways, (i) non-canonical
Wnt signaling, (ii) epithelial to mesenchymal transition
(EMT), and (iii) the Ets-1 pathway, contain multiple dif-
ferentially expressed genes and were chosen as examples
of cases where disruption of SUMOylation can be re-
lated to the observed phenotypes.
Non-canonical Wnt/PCP signaling
Wnt signaling can be divided into two broad groups, ca-
nonical and non-canonical, based on outcome. Canon-
ical signaling is dependent on β-catenin and regulates
transcription of target genes, while non-canonical is in-
dependent of β-catenin and regulates cell polarity and
calcium levels [43]. The non-canonical signaling pathway
leads to activation of Rho and reorganization of the
cytoskeleton and changes in cell polarity. Specific Wnt
proteins are classified as canonical or non-canonical
based on their ability to induce secondary axes in Xen-
opus embryos. The latter, which includes Wnt4, Wnt5a,
and Wnt11 [44–46] have little or no dorsalizing effect
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and do not activate known Wnt target genes such as
nodal3.1 (Xnr3) and sia1 (Siamois), whose expression is
not changed in Gam1 embryos.
Several Wnt and Fzd genes are misregulated in
SUMOylation deficient embryos (Fig. 5). Three Fzd
genes of the non-canonical pathway (fzd2, fzd7 and
fzd10) are down regulated at one or more time points.
Two Wnt genes (wnt8b and wnt11) are also down regu-
lated. Wnt8b has not been specifically implicated in
non-canonical signaling; however, it is often placed in
the same group as Wnt11, since both have similar tem-
poral roles, activating canonical pathways in oocytes and
pre-MBT embryos, but non-canonical pathways during
gastrulation [47, 48]. Both Wnt8 and Wnt11 can bind to
Fzd7 [49].
While Fzd2 and Fzd7 have been implicated in planar
cell polarity (PCP), the interaction of the latter receptor
with Wnt11 ligand appears to be the major determinant
of this process [50–53]. Therefore, the observed decrease
in both these receptors and ligands can account for the
effect of Gam1 on convergent extension. An early mani-
festation of convergent extension/PCP is closure of the
blastopore, which is generally delayed and often incom-
plete in Gam1 embryos (Fig. 2a) and is specifically at-
tributed to forces generated by convergent thickening
(CT) [54]. Convergent extension underlies the intercal-
ation of mesodermal cells that drives the elongation of
the A–P axis, which is also compromised in the
SUMOylation deficient embryos. Both Wnt 11 and Fzd7
have been implicated in A–P axis elongation. A constitu-
tively active form of the Rho GTPase, Cdc42, rescues
axis elongation effects caused by expression of a trun-
cated form of Fzd7, while a dominant negative form of
Cdc42 rescues the inhibition of axis elongation that oc-
curs with Wnt11 and Fzd7 overexpression [50]. In some
cases, Fzd7 and Fzd2 act redundantly in convergent ex-
tension [55], which likely accounts for the high pene-
trance of convergent extension phenotypes in Gam1
embryos, since we measure a decrease in expression of
both receptors during late gastrula.
Disruption of the non-canonical Wnt pathway can also
account for the cardiac and neural tube defects that
occur later in embryo development. Wnt 11 and Fzd7
are required at multiple points during Xenopus heart
Fig. 5 Changes in gene expression in the non-canonical Wnt/PCP signaling pathway. Decreased mRNA levels in Gam1 embryos relative to
control embryos is represented by green and increased levels by red. Documented targets of SUMOylation are indicated. Transcriptional
regulation is denoted by blue arrows and signaling through protein-protein interactions by black arrows. Log (2) changes in gene expression are
listed for the three experimental time points
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development, not only early in the specification of car-
diac progenitor cells, but also in cardiac morphogenesis
(septation and outflow tract development) [56–61]. The
ensuing decreased activity of Dishevelled (Dvl) in
Gam1 embryos is fully consistent with the cardiac
and neural tube phenotypes of Dvl-deficient mice and
Xenopus [62–64].
Two other PCP core components, Vangl2 and Prickle3,
are modestly reduced at early neurula stage, a period
when a complex of these two proteins is required for the
radial cell intercalations that sustain neural tube closure
[65, 66]. Notably, the polarization of the Prickle3/Vangl2
complex to anterior cell edges has been linked to Wnt11
signaling [67]. Vangl2 also plays a critical role in heart
formation that is independent of neural tube closure. In
mice, knock down of Vangl2 specifically in undifferenti-
ated cells of the second heart field prevents lengthening
of the outflow tract due to a failure of these cells to
polarize and differentiate [68]. These early abnormalities
lead to later defects in cardiac morphology. Decreased
expression of several members of the non-canonical
Wnt signaling pathway combined with those of the PCP
pathway can account for the most prominent phenotypes
of the SUMOylation-deficient Xenopus embryos and
strongly suggest that disruptions in this post-translational
modification potentially underlie congenital birth defects
of the neural tube and heart [30, 69].
Because several Wnt and Fzd genes are down regulated
in the Gam1 embryos, it is reasonable to speculate that they
share one or more common transcriptional regulators that
can coordinate their expression; however, it has not been
possible to discern a single master regulator. Transcription
factor network building indicated p53 activity as the most
likely source for dysregulation of non-canonical Wnt sig-
naling. At all three time points, p53 is in the top five tran-
scription factors most highly connected to differentially
expressed genes. Surprisingly, p53 shows a two-fold in-
crease in expression at late gastrula in Gam1 embryos.
However, regulation of p53 activity by SUMOylation is
complex with the modification having a positive, negative,
or no effect depending on the target gene in question [70].
Moreover, ANKRD11, a coactivator of p53 [71], shows a
five-fold decrease in expression by early neurula stage. Our
results indicate that SUMOylation of p53 and/or one of its
partners plays a critical role in the regulation of
non-canonical Wnt pathway genes during Xenopus gastru-
lation and neurulation (Fig. 5). In addition, decreased ex-
pression of transcription factors GATA6 [72], Pitx2 [73],
and T2 (Xbra3) [74] can also contribute specifically to the
decrease in wnt11 mRNA expression (Fig. 5).
Epithelial to mesenchymal transition
The epithelial to mesenchymal transition (EMT) is a
hallmark of early vertebrate development and patterning
of the embryo [75, 76]. In Xenopus, EMT changes allow
for the presumptive mesoderm to migrate inward during
gastrulation, and disruptions in EMT signaling lead to
developmental defects in gastrulation and later pattern-
ing of the embryo [77]. One important pathway involves
control of EMT genes by the transcription factors snail 1
(snai1) and twist (twist1) [75, 76, 78]. Although the ex-
pression of snai1 and twist1 genes requires high mobility
group A-T hook 2 (HMGA2), the two genes appear to
be under distinct regulatory control [79]. HMGA2 bind-
ing to the snai1 promoter involves formation of a com-
plex with phosphorylated SMADs activated by TGFβ
signaling [80]. Conversely, HMGA2 is able to bind dir-
ectly to the twist1 promoter in the absence of TGFβ sig-
naling [79, 80]. HMGA2 is a known target of
SUMOylation [81, 82] that has been directly implicated
in Xenopus EMT and migration of neural crest cells [83]
as well as Xenopus cardiogenesis [84]. The different be-
havior of HMGA2 at the snai1 and twist1 promoters is
reflected in the different effect of Gam1 on the expres-
sion of these two genes. Twist expression was reduced at
all three time points. In contrast, no misregulation of
snai1 was observed.
The microarray analysis detected disruptions in the
twist/snail pathway that potentially increase epithelial
and decrease mesenchymal characteristics that contrib-
ute to the observed gastrulation defects and failure of
the blastopore to close (Fig. 6). Twist and Snail1 form a
complex to control expression of the EMT-specific tran-
scription factor, Zeb-2, which is down regulated 1.3-fold
at early neurula. Zeb-2 is responsible both for activation
of genes that promote a mesenchymal phenotype and re-
pression of genes that promote an epithelial phenotype
[85]. Moreover, Zeb-2 is a target of SUMOylation, which
controls its activity in a promoter-specific fashion [86].
ZO-2 (tjp2), an integral component of tight junctions
normally down-regulated by Zeb-2 in mesenchymal
cells, allowing for increased cell movement, is
up-regulated at late gastrula and early neurula in Gam1
embryos. Vimentin (vim), claudin 4 (cldn4), and con-
nexin26 (gjb2) normally up regulated in mesenchymal
cells, are down regulated in Gam1 embryos [87, 88].
SUMO possibly impacts this pathway at a second
point. NF-κB/p65 an activator of Twist and Zeb2 expres-
sion [89], is regulated by a negative feedback loop in-
volving the SUMOylation of the p65 (RELA) subunit
[90] that can account for the decreased expression these
two transcription factors. In combination, the altered ex-
pression of the proteins in this pathway is expected to
contribute to an epithelial-like character that impedes
cell migration during gastrulation and neurulation,
resulting in phenotypes such as the observed incomplete
closure of the neural tube and shortened A–P axis. On
the other hand, the constant level of snail1 expression
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can account for the unperturbed levels that we measure
of other regulators of the EMT (e.g., E-cadherin,
N-cadherin, fibronectin, and occludin).
Ets-1 pathway
Pathway analysis of the microarray data revealed that
perturbation of Ets-1 activity is another likely contribu-
tor to the phenotypes exhibited by Gam1 embryos [91–
94]. The regulation of Ets-1 during development is com-
plex and occurs through the integration of multiple
types of post-translational modification: phosphorylation,
acetylation, ubiquitination, and SUMOylation [92, 94,
95]. Furthermore, Ets factors can either enhance or re-
press transcription [96]. Ets-1 can be SUMOylated at
two lysine residues (K15 and K227), resulting in the loss
of transcriptional activation activity [92]. Conversely,
Ets-1 phosphorylated at threonine 38 by MAPK, as a re-
sult of Ras activation, increases its transcriptional activa-
tion activity (Fig. 7). The SUMOylation of two targets in
the Ras/Raf-MEK-MAPK phosphorylation pathway in-
directly influence Ets-1. Ras-1 is a target for SUMO
modification, which is required for Ras-dependent acti-
vation of MAPK [97]. In contrast, SUMOylation of the
downstream target MEK blocks its interaction and acti-
vation of MAPK [98]. Down regulation of several genes
controlled by Ets-1 in Gam1 embryos indicates that in-
activation of the Ras pathway and the resulting dephos-
phorylation of Ets-1 has the greatest impact on the
activity of this transcription factor.
Knockdown of Ets-1 in Xenopus neural crest cells re-
sults in defects in delamination of the neural tube and
disruption of cell migration that lead to malformed out-
flow tracts of the heart; whereas, depletion of Ets-1 ac-
tivity in heart mesoderm results in distinct phenotypes
that include loss of the entire endocardium and failure
to form discrete chambers [93]. Two Ets-1 target genes,
platelet derived growth factor α (pdgfa) and PDGFα re-
ceptor (pdgfra), are down regulated. There is abundant
evidence that PDGFα is necessary very early in heart de-
velopment for the proper migration of cardiomyocytes
to the midline and formation of the heart tube [99–101].
Ets-1 works in concert with Sp1 to activate transcription
of the PDGFα gene [102]. Like Ets-1, Sp1 is repressed by
SUMOylation [103] and activated by MAPK [104], po-
tentially amplifying the effect of Gam1 on the expression
of pdgfa and pdgfra.
Gastrulation defects in developing Xenopus embryos
are also observed when PDGFα signaling is disrupted
[105–107]. PDGFα is expressed in the blastocoel roof of
the developing embryo and its receptor is expressed in
the migrating mesoderm. This complementary expres-
sion of ligand and receptor orients and directs the move-
ment of mesodermal cells inward during gastrulation.
Interfering with PDGFα signaling randomizes internal
movement of these cells and prevents proper convergent
extension [106]. This disruption leads to improper pat-
terning and phenotypes that include incomplete blasto-
pore closure and shortened axis elongation. Mice with
mutations in the PDGFαR display severe skeletal abnor-
malities, cleft face, and spina bifida [108, 109], with the
latter being a frequent phenotype in Gam1 embryos.
While the disruption of Ets-1 (and Sp1) activity can
account for the immediate effects on PDGFα and its re-
ceptor, we note that there are also several downstream
changes in gene expression that can contribute to the
phenotypes of Gam1 embryos, including DUSP1 (cell
migration) [110] and IGF2 (neural and eye development)
[111, 112]. Of particular note, is the increased expression
of the transcription factor Egr1 (late gastrula) which is a
positive regulator of MyoD and a negative regulator of
Xbra [113]. Consistent with the change in Egr1, we
measure increased expression of MyoD (late neurula)
and decreased Xbra expression (late gastrula/early neu-
rula). Both MyoD and Xbra are critical factors in several
developmental pathways.
Fig. 6 Changes in gene expression in the Twist/Snail pathway.
Decreased mRNA levels in Gam1 embryos relative to control
embryos is represented by green and increased levels by red.
Documented targets of SUMOylation are indicated. Transcriptional
regulation is denoted by black arrows. Log (2) changes in gene
expression are listed for the three experimental time points
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Conclusions
It is now appreciated that SUMO impinges on a sub-
stantial number of biological processes, explaining why
deletion of E2 conjugating enzyme is embryonic lethal in
mice and zebrafish [2, 8, 11–13]. For this reason, it has
been difficult to assess the role of this post-translational
modification in live animals. While the magnitude of
many of the changes in gene expression in Gam1 em-
bryos is modest, the cumulative effect of disrupting mul-
tiple pathways that impinge upon a particular
developmental event accounts for the frequency of the
commonly observed phenotypes. The experiments here
make evident that regulation by SUMO during the earli-
est period of embryogenesis is critical to proper develop-
ment at later stages. Injection of Gam1 mRNA
suppressed SUMOylation activity up to late neurula (26
hpf), yet generated phenotypes that appear later in de-
velopment (e.g., heart looping, 48 hpf), demonstrating
the early embryonic origins that give rise to the two
most common human birth defects: heart and neural
tube. Transcriptome analysis has revealed those path-
ways that are most susceptible to diminished SUMOyla-
tion activity. The frequent occurrence of heart defects in
Gam1 embryos is in accord with the prominent role
SUMO plays in the regulation of cardiac gene expression
[114, 115]. Indeed, in a cohort of 87 babies exhibiting
atrial septal defects, five carried mutations that reduced
the promoter activity of the SUMO1 gene [30], demon-
strating a direct connection between deficits in this post-
translational modification and congenital heart defects.
It is also clear from the experiments described here that
the PCP pathway is exceptionally sensitive to depressed
SUMOylation activity and this most certainly accounts
for the frequent neural tube defects of the Gam1 em-
bryos [116, 117] and supports a proposed relationship
between the PCP pathway and risk for spina bifida [69].
Our transcriptomics analysis has identified disruptions
in pathways that have especially great potential to con-
tribute to these pathologies and that warrant closer clin-
ical examination. Targeted inhibition of SUMOylation
activity by Gam1 will be useful for further investigation
of this post-translational modification and its causative
role in birth defects.
Methods
Embryo preparation
Female X. laevis were injected with 500 units of human
chorionic gonadotropin (HCG) at least 12 h prior to
spawning. Testes were isolated and stored at 4 °C in high
salt MBS (0.7 mM CaCl2, 108 mM NaCl, 1 mM KCl, 1
mM MgSO4, 5 mM HEPES, pH 7.8, 2.5 mM NaHCO3)
for up to a week. Minced testis and eggs were mixed to-
gether with 3 mL 1/3 MMR (0.1M NaCl, 2.0 mM KCl, 1
mM MgSO4, 2 mM CaCl2, 5 mM HEPES, pH 7.8) and
left to fertilize at room temperature. After 10 min, eggs
were flooded with additional 1/3 MMR and after an add-
itional 30 min eggs were washed with 2% cysteine (< 5
min) in order to remove the jelly coating, upon which
eggs were washed 8 times with 1/3 MMR. Embryos were
injected in the animal hemisphere (volumes ranged be-
tween 5 to 30 nl) and allowed to develop at room
temperature in 1/3 MMR. At least 30 min prior to
Fig. 7 Changes in gene expression in the Ets-1 pathway. Decreased mRNA levels in Gam1 embryos relative to control embryos is represented by
green and increased levels by red. Documented targets of SUMOylation are indicated. Connections by arrows represent activation and T-bars
represent inhibition. Log (2) changes in gene expression are listed for the three experimental time points
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harvest of the testes, the male frog is submerged in an
ice water bath using a mesh basket to keep the ice away
from the skin surface. The frog is decapitated, and
pithed prior to removal of the testes. After removal of
the testes tissue, the heart is cut and the frog pithed to
ensure death prior to disposal. Female frogs are rested at
least 3 months between spawnings.
RNA synthesis
Linearized plasmid (2.5 μg) was added to a mixture con-
taining transcription buffer (Promega), 10 mM DTT, 2.5
mM cap analog, 50 units RNasin, 200 units RNA poly-
merase, and 0.5 mM each UTP, ATP, CTP, GTP in a
total volume of 50 uL. The reaction was incubated at 37
°C for 90 min, followed by the addition of another 200
units of polymerase and incubation for 90 additional mi-
nutes. The reaction mixture was extracted twice with
phenol pH 4.5 and twice with 24:1 chloroform: isoamy-
lalcohol. The mRNA was precipitated with ethanol, sus-
pended in 50 ul of H2O and run though a NucAway
spin column (Ambion) to remove unincorporated nucle-
otides. mRNA concentrations were determined using a
NanoDrop spectrometer (Thermo Scientific), and sam-
ples were stored at − 80 °C until use.
SUMOylation assays
Gam1 mRNA was injected into one-cell embryos, which
were allowed to develop to the indicated stage (midblas-
tula, late blastula, early gastrula, and midneurula).
Twenty embryos per time point were homogenized in
22 uL of SUMO reaction buffer (Boston Biochem) and
spun at 16,000 rcf for 5 min. Supernatant was removed
and the protein concentration was determined by Brad-
ford assay. Each assay conatined 25 μg of whole cell ex-
tract, 60 uM SUMO1, 5 uM Ubc9, 5 uM E2-25K
(substrate peptide), 25 mMMg-ATP in a total reaction
volume of 25 uL. Control reactions contained 500 nM
SAE1/SAE2 (E1 enzyme) in place of cell extract. Reac-
tions were incubated at 37 °C for four hours. SDS load-
ing dye was mixed with the reactions and vortexed
briefly in order to stop the reaction. Assays were ana-
lyzed by SDS polyacrylamide gel electrophoresis
followed by western blot.
Western blots
Gam1 carries a single (10 amino acid) N-terminal myc
tag that was detected using c-myc antibody (sc-40, Santa
Cruz Biotechnology) at 1:500 dilution. For SUMOylation
assays an antibody (A-603, Boston Biochem) directed
against the SUMO1 substrate peptide (E-25 K) was used
at 1:500 dilution. All blots were visualized using a goat
anti-rabbit IgG:alkaline phosphatase fusion protein at
1:3000 dilution in conjunction with BCIP/NBT color de-
velopment (Bio-Rad).
Keller sandwich explant assays
One-cell embryos injected with either Gam1 mRNA
(2.5 ng or 5.0 ng) or an equivalent volume of H2O and
allowed to develop in 1/3 MMR until early gastrula stage
(~ 9 hpf) when the blastopore lip was initially beginning
to form. Embryos were maintained in 1× MBS buffer
(88 mM NaCl, 1 mM KCl, 0.7 mM CaCl2, 1 mM MgSO4,
5 mM HEPES pH 7.8, 2.5 mM NaHCO3) during the dis-
section, which followed the procedure described, by Kel-
ler and Danilchik (1998).
Once the sandwich was fabricated, it was cultured in
the dissection dish for one hour allowing the explants to
adhere. Explant sandwiches were then moved to an
agarose-coated Petri dish containing 1X MBS supple-
mented with 50 μg/mL gentamicin and left to culture
for an additional 14 h. Samples were photographed im-
mediately after moving them to the Petri dish (10 hpf)
and again at 24 hpf using an Olympus SZX16 micro-
scope. Scale bars on the CellSens software were used to
measure the length and width of the sandwich at the
mentioned time points. Explants from water-injected or
Gam1-injected embryos were compared to each other to
determine the level of convergence and extension. Sam-
ple sets were analyzed for significant differences using a
Student’s T-Test.
Microarray analysis
One cell embryos were injected with either 0.5 ng Gam1
mRNA in a total volume of 9.2 nL or with H2O as a con-
trol. Embryos were allowed to develop in 1/3 MMR at
room temperature until the desired time points. Samples
were taken at early gastrula (9 hpf ), late gastrula (13.5
hpf) and early neurula (16.5 hpf). Twenty embryos from
each time point were homogenized in 500 uL proteinase
K buffer (100 mM Tris pH 8, 150 mM NaCl, 12.5 mM
EDTA pH 8.0, 1% SDS, 200 μg proteinase K) and incu-
bated at 37 °C for one hour. Samples were then extracted
twice with an equal volume of phenol, pH 4.5, and twice
with 24:1 chloroform:isoamylalcohol. RNA was purified
using an RNAEasy spin column (Qiagen, #74104) and
precipitated with 2.5 volumes of ice-cold ethanol. The
concentration and purity of the samples was determined
using a NanoDrop spectrometer. Prior to microarray
data collection, the RNA integrity number (RIN) for
each sample was determined by the Notre Dame Gen-
omics and Bioinformatics Core Facility (GBCF) using an
Agilent 2100 BioAnalyzer.
Total RNA (50–500 ng) was used for cDNA synthesis
according to the GeneChip 3′ IVT Express Kit for Affy-
metrix microarray chips. The cDNA was then converted
to double-stranded DNA and used as a template for
transcription of amplified RNA (aRNA) which was la-
beled with a biotin-conjugated nucleotide. aRNA sam-
ples (15 μg) were subsequently purified and fragmented
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to produce probes for hybridization onto Xenopus laevis
2.0 GeneChip 3’expression arrays. Three biological repli-
cates were carried out for Gam1 and H2O injected sam-
ples at each time point utilizing a total of 18 microarray
chips. Analysis of the microarray chips was carried out
with the Affymetrix GeneChip System. Affymetrix .cel
files were analyzed using the Bioconductor software
package (http://www.bioconductor.org/). The mean
fluorescence intensity was derived from a log2 trans-
formation of the data and normalized using the quantile
normalization method. A Student’s t test was used to de-
termine if there was a significant difference between the
Gam1 and H2O embryo gene expression values. A p
value less than 0.05 was used as a cut off for differential
expression. The fold change, between control and Gam1
samples, for each expression value was also calculated.
Gene lists for those genes differentially expressed (p <
0.05) were compiled for bioinformatics analysis. Since
the Xenopus laevis genome is not fully annotated, some
probes on the 2.0 chip, which do not have identified
names or functions; only annotated genes were used for
bioinformatics analysis.
Microarray data analysis: MetaCore
Gene lists were uploaded to the MetaCore software suite
of programs; only annotated genes were used for each
analysis and genes were grouped differently depending
on the analysis. Genes were grouped into lists based on
differential expression at each time point (EG, LG, EN),
not-differential expression at each time point (EG, LG,
EN), or common expression patterns across all three
time points (Cluster 1–8). MetaCore was used to analyze
the gene lists for (i) transcription factor networks, (ii)
functional enrichment, and (iii) pathway analysis each
using an algorithm with specific well-defined instruc-
tions for creating the network based on established
interactions.
In order to remove the redundancies created by the
MetaCore enrichment algorithms, GeneGo IDs identi-
fied in the initial analysis were further categorized using
GO Term classification software CateGOrizer (v. 3.218).
Gene ontologies are hierarchically organized and the
CateGOrizer software allows the specific sub-terms to
be grouped into their broader categories providing a
more accurate enrichment picture.
Pathway maps in MetaCore are created by compiling
known biochemical processes or signaling cascades into
graphical images. These maps can be used to determine
the interconnectedness of uploaded genes in a biological
context. Additionally, pathway maps can be used to de-
termine downstream gene targets not present on the
microarray. Gene lists were uploaded into MetaCore
while pathways relevant to development (heart and ner-
vous system), cell adhesion, cell cycle, cytoskeleton
remodeling, and epithelial to mesenchymal transition
were manually searched for any matching genes. Path-
ways containing differentially regulated genes were ana-
lyzed further for their connection to the observed
developmental phenotypes.
Identification of SUMO consensus sequences and SIMs
Potential sites of SUMOylation and SUMO interaction
motifs (SIM) were identifed using GPS–SUMO (http://
sumosp.biocuckoo.org/) using the low threshold setting
for the former. X. laevis reference sequences were
accessed through XenBase (http://www.xenbase.org).
Real time polymerase chain reaction
RNA samples (4 μg) were mixed with random hexamers
(Promega, #C118A) and heated at 70 °C for 5 min. Sam-
ples were then placed on ice for at least 5 min. Reverse
transcription reactions containing 1 uL GoScript reverse
transcriptase (Promega, #A501C) in a final volume of 20
uL were placed in a thermal cycler with program se-
quence: 25 °C for 10 min, 42 °C for 50 min, 70 °C for 15
min. Dilution calculations of the reverse transcription
(RT) reaction were based on a proportional amount of
cDNA being created from the total RNA added to the
reaction thereby producing a solution with a cDNA con-
centration of 200 ng/uL. RT samples were diluted with
H2O to give a final cDNA concentration of 5 ng/uL. An
aliquot of 50 uL of cDNA was mixed with an additional
200 uL of H2O to give a final working concentration of
1 ng/uL which was used in SYBR green PCR reactions.
An additional 50 uL aliquot of each 5 μg/uL RT sample
was taken in order to make standard curve dilutions for
testing primer efficiency. A four point standard curve
was created with 10 fold dilutions from the 5 ng/uL
cDNA arbitrarily termed: 1000 (undiluted), 100, 10, and
1. A standard curve was generated for each primer pair
in order to test the primer efficiency. A master mix con-
taining 25 uM of both forward and reverse primers and
12.5 uL SYBR Green Master Mix (Applied Biosystems,
#4309155) was prepared for each sample. The master
mix (15 uL) and cDNA (10 ul) was added to each well of
a 96 well plate. Samples were run with the following
program parameters: 50 °C for 2 min, 95 °C for 15 min,
95 °C for 15 s, 60 °C for 30 s, 72 °C for 30 s (last three
steps repeated for 45 cycles), 95 °C for 15 s, 60 °C for 1
min, ramping temperature for 20 min, 95 °C for 15 s.
The ramping temperature function was used to produce
melt curves for calculation of primer efficiency.
Additional files
Additional file 1: Figure S1. Heatmap showing the hierarchical
clustering of all differentially expressed genes (DEGs) identified from
comparisons between control (water injected) and Gam1 injected
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embryos at the three developmental stages (early gastrula, late gastrula,
and early neurula, respectively). Numbers refer to the individual biological
triplicates. (XLSX 323 kb)
Additional file 2: Table S1. Gene expression data matrix associated
with the heatmap as shown in Additional file 1: Figure S1. Genes and
expression values in the matrix are listed in the same order as they
appear in heatmap. (XLSX 34 kb)
Additional file 3: Figure S2. Comparison of microarray data with
measurement by qRT-PCR. The fold change between Gam1 and control
embryos for the indicated gene as measured by microarray and qRT-PCR
are compared with each pair of bars corresponding to early gastrula, late
gastrula, and early neurula, respectively. Asterisks indicate samples in
which the RNA level was too low to measure by qRT-PCR. (DOCX 157 kb)
Additional file 4: Figure S3. Volcano plots of differentially expressed
genes between Gam1 and control embryos. Fold change (log2) is plotted
versus statistical significance at (A) early gastrula, (B) late gastrula, and (C)
early neurula. Significance values of p < 0.05 (black line) indicates the cut
off for accepted differential expression. (DOCX 22 kb)
Additional file 5: Table S2. Gene Lists Constituting the Biological
Processes Most Affected by Loss of SUMOylation Activity. (TIF 66126 kb)
Additional file 6: Table S3. Biological Processes Associated with
Transcription Factors Identified in Network Building. (TIF 21375 kb)
Additional file 7: Table S4. SUMO Targets Sites and SUMO Interaction
Motifs (SIM) in Top Transcription Factors from Network Building. (TIF
21809 kb)
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